Yahoo Finance

Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)

First published data from a multicenter retrospective chart review study to explore the safety and efficacy of pyrimidine nucleoside and/or nucleotide therapy in patients with thymidine kinase 2 ...
News Medical

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), identified as the causative agent of the COVID-19 (coronavirus disease 2019) pandemic, was first detected in Wuhan, China late December ...
News Medical

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Coronavirus disease 2019 (COVID-19) overwhelmed healthcare services worldwide when it first emerged, and the lack of immediate treatment frustrated healthcare workers. Instead of treating the ...
ascopubs.org

Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors.

First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients (pts) with advanced solid tumors. This is an ASCO Meeting Abstract from the 2019 ASCO ...
PharmiWeb

Methods of Nucleoside Bond Formation

Nucleotides are the phosphate esters of nucleoside and are the building blocks of DNA and RNA. All nucleotides have three components: a nitrogen-containing heterocyclic base, a pentose sugar, and a ...
Morningstar

Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)

ATLANTA, Oct. 13, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Neurology has published results from a multicenter retrospective chart review study of ...